Influence of antipsychotics on mortality in schizophrenia: Systematic review

@article{Weinmann2009InfluenceOA,
  title={Influence of antipsychotics on mortality in schizophrenia: Systematic review},
  author={S. Weinmann and J. Read and V. Aderhold},
  journal={Schizophrenia Research},
  year={2009},
  volume={113},
  pages={1-11}
}
BACKGROUND Antipsychotic medication is the cornerstone of schizophrenia treatment. The impact of long-term exposure to antipsychotics on life-expectancy has recently received some attention, partly because awareness is increasing of the differential mortality of people with schizophrenia and the general population. METHODS A systematic review of studies assessing the association between antipsychotic exposure and mortality in persons with schizophrenia was undertaken. RESULTS In total, 12… Expand
Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis
Antipsychotic treatment and mortality in schizophrenia.
Doubtful association of antipsychotic polypharmacy and high dosage with cognition in chronic schizophrenia
Polypharmacy in schizophrenia
All-Cause Mortality and Medication Risk Factors in Schizophrenia: A Prospective Cohort Study
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 44 REFERENCES
Mortality in schizophrenia. Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study.
Validation of polypharmacy process measures in inpatient schizophrenia care.
Serious Cardiovascular Events and Mortality Among Patients with Schizophrenia
Schizophrenia, neuroleptic medication and mortality
Physical health and schizophrenia
Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study
Atypical antipsychotic drugs and the risk of sudden cardiac death.
A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?
...
1
2
3
4
5
...